Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis

Phase 3 Completed 855 enrolled Merz North America, Inc.

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of NAFT-600, applied once daily for 2 weeks, when compared to placebo for 2 weeks in the treatment of subjects with tinea pedis.

Timeline

Start: 2011-02
Primary completion: 2011-11
Completion: 2012-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Naftifine	Other / unclassified	2 %	Topical

Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis

Summary

Timeline

Drugs

Indications